SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004541
Filing Date
2021-11-15
Accepted
2021-11-15 13:48:21
Documents
92
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atai-20210930.htm   iXBRL 10-Q 6374850
2 EX-31.1 atai-ex31_1.htm EX-31.1 16703
3 EX-31.2 atai-ex31_2.htm EX-31.2 16890
4 EX-32.1 atai-ex32_1.htm EX-32.1 10933
5 EX-32.2 atai-ex32_2.htm EX-32.2 10921
6 GRAPHIC img104097429_0.jpg GRAPHIC 48842
  Complete submission text file 0000950170-21-004541.txt   25358550

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atai-20210930_pre.xml EX-101.PRE 727746
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atai-20210930_lab.xml EX-101.LAB 824339
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atai-20210930_def.xml EX-101.DEF 556644
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atai-20210930.xsd EX-101.SCH 124486
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atai-20210930_cal.xml EX-101.CAL 62764
12 EXTRACTED XBRL INSTANCE DOCUMENT atai-20210930_htm.xml XML 6442530
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40493 | Film No.: 211408829
SIC: 2834 Pharmaceutical Preparations